DK0525307T3 - Stabile præparater til parenteral indgivelse og deres anvendelse - Google Patents

Stabile præparater til parenteral indgivelse og deres anvendelse

Info

Publication number
DK0525307T3
DK0525307T3 DK92107277.3T DK92107277T DK0525307T3 DK 0525307 T3 DK0525307 T3 DK 0525307T3 DK 92107277 T DK92107277 T DK 92107277T DK 0525307 T3 DK0525307 T3 DK 0525307T3
Authority
DK
Denmark
Prior art keywords
compounds
parenteral administration
lambda
warm
alpha
Prior art date
Application number
DK92107277.3T
Other languages
English (en)
Inventor
William David Steber
Susan Mancini Cady
Phillip Wayne Hayes
Mary Ehlers Doscher
Kurt Allen Schwinghammer
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of DK0525307T3 publication Critical patent/DK0525307T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK92107277.3T 1991-07-23 1992-04-29 Stabile præparater til parenteral indgivelse og deres anvendelse DK0525307T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73443091A 1991-07-23 1991-07-23

Publications (1)

Publication Number Publication Date
DK0525307T3 true DK0525307T3 (da) 1996-04-01

Family

ID=24951666

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92107277.3T DK0525307T3 (da) 1991-07-23 1992-04-29 Stabile præparater til parenteral indgivelse og deres anvendelse

Country Status (21)

Country Link
US (1) US6340671B1 (da)
EP (1) EP0525307B1 (da)
JP (1) JP3470904B2 (da)
KR (1) KR100235550B1 (da)
CN (1) CN1046852C (da)
AT (1) ATE134873T1 (da)
AU (1) AU651229B2 (da)
BR (1) BR9202771A (da)
CA (1) CA2074348C (da)
DE (1) DE69208765T2 (da)
DK (1) DK0525307T3 (da)
ES (1) ES2086022T3 (da)
GR (1) GR3019234T3 (da)
HK (1) HK1000005A1 (da)
HU (1) HU220595B1 (da)
IE (1) IE74401B1 (da)
IL (1) IL102567A (da)
MX (1) MX9204135A (da)
NZ (1) NZ243619A (da)
TW (1) TW201696B (da)
ZA (1) ZA925522B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5733566A (en) * 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
US5643595A (en) * 1992-11-24 1997-07-01 Alkermes Controlled Therapeutics Inc. Ii Growth promoters for animals
DE4308282C2 (de) * 1993-03-16 1994-12-22 Beiersdorf Ag Vorzugsweise in Form von Mikrosphärulen vorliegende galenische Matrices
DE19613972A1 (de) * 1996-04-09 1997-10-16 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl
DE19638045A1 (de) * 1996-09-18 1998-03-19 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen
US8663692B1 (en) * 1999-05-07 2014-03-04 Pharmasol Gmbh Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same
WO2000067728A2 (de) * 1999-05-07 2000-11-16 Pharmasol Gmbh Lipidpartikel auf der basis von mischungen von flüssigen und festen lipiden und verfahren zu ihrer herstellung
ES2304371T3 (es) * 2000-10-10 2008-10-16 Wyeth Holdings Corporation Composiciones estables para administracion parenteral.
FR2852843B1 (fr) 2003-03-24 2008-05-23 Karim Ioualalen Systeme galenique permettant le masquage du gout
NZ534939A (en) * 2004-08-26 2007-04-27 Bomac Research Ltd Injectable formulation comprising an anthelmintic compound with complexing compound for improved solubility
WO2011043962A2 (en) 2009-10-07 2011-04-14 Wyeth Llc Compositions comprising adjuvant, macrolide and proteinaceous antigen and methods of use thereof
ITUB20153652A1 (it) * 2015-09-16 2017-03-16 Fatro Spa Microsfere contenenti lattoni macrociclici antielminitici
PL3609470T3 (pl) 2017-04-13 2024-04-15 Ceva Santé Animale Implant do leczenia infekcji pasożytniczej
BR112021016432A2 (pt) * 2019-02-21 2021-11-09 Chromadex Inc Composição que compreende prills de cera, processo para produzir prills de cera, composição nutricional, alimento, bebida ou suplemento alimentar que compreende prills de cera, e composição que compreende microesferas encapsuladas
BR112021021649A2 (pt) 2019-05-03 2021-12-21 Intervet Int Bv Composições farmacêuticas injetáveis e usos das mesmas
ES2969653T3 (es) 2020-05-20 2024-05-21 Intervet Int Bv Composiciones farmacéuticas inyectables y usos de las mismas
WO2022263505A1 (en) * 2021-06-16 2022-12-22 Société des Produits Nestlé S.A. Methods of solid phase wax coating of an active ingredient
WO2024003291A1 (en) 2022-06-30 2024-01-04 Virbac Deslorelin use in chemical castration of a non-human mammal related to pk/pd interaction

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3659022A (en) * 1967-11-13 1972-04-25 Upjohn Co Methods of preventing impregnation
US4144352A (en) * 1977-12-19 1979-03-13 Merck & Co., Inc. Milbemycin compounds as anthelmintic agents
US5169956A (en) * 1984-06-05 1992-12-08 American Cyanamid Company Macrolide antibiotic compounds
US5106994A (en) * 1984-06-05 1992-04-21 American Cyanamid Company Agents and method of production thereof
EP0257368B1 (en) * 1986-08-11 1992-03-25 American Cyanamid Company Compositions for parenteral administration and their use
GB8803836D0 (en) * 1988-02-18 1988-03-16 Glaxo Group Ltd Compositions
DE69007515T2 (de) * 1989-02-28 1994-11-03 American Cyanamid Co Bolus mit lang andauernder Wirkstoffabgabe, wirksam bei der Prophylaxe, Behandlung oder Bekämpfung des Befalls bei Wiederkäuern durch Fadenwürmer, Milben und Endo- und Ektoparasiten.
US5213810A (en) * 1990-03-30 1993-05-25 American Cyanamid Company Stable compositions for parenteral administration and method of making same
US5346698A (en) * 1991-01-15 1994-09-13 Mycogen Corporation Synergistic pesticidal compositions
US5192546A (en) * 1991-01-15 1993-03-09 Mycogen Corporation Synergistic pesticidal compositions
US5185108A (en) * 1991-07-10 1993-02-09 The B. F. Goodrich Company Method for producing wax microspheres
JP4654917B2 (ja) 2006-01-12 2011-03-23 日産自動車株式会社 車体後部構造

Also Published As

Publication number Publication date
CN1046852C (zh) 1999-12-01
IE74401B1 (en) 1997-07-30
IE922373A1 (en) 1993-01-27
IL102567A0 (en) 1993-01-14
DE69208765D1 (de) 1996-04-11
ES2086022T3 (es) 1996-06-16
KR930001904A (ko) 1993-02-22
DE69208765T2 (de) 1996-09-26
KR100235550B1 (ko) 1999-12-15
CN1068735A (zh) 1993-02-10
EP0525307A1 (en) 1993-02-03
GR3019234T3 (en) 1996-06-30
CA2074348A1 (en) 1993-01-24
NZ243619A (en) 1994-12-22
BR9202771A (pt) 1993-03-23
CA2074348C (en) 2004-02-17
JPH05194211A (ja) 1993-08-03
IL102567A (en) 1996-10-31
ZA925522B (en) 1993-04-28
HU220595B1 (hu) 2002-03-28
TW201696B (da) 1993-03-11
HUT62454A (en) 1993-05-28
AU2047292A (en) 1993-01-28
JP3470904B2 (ja) 2003-11-25
MX9204135A (es) 1993-01-01
EP0525307B1 (en) 1996-03-06
ATE134873T1 (de) 1996-03-15
HK1000005A1 (en) 1997-10-03
US6340671B1 (en) 2002-01-22
HU9202404D0 (en) 1992-10-28
AU651229B2 (en) 1994-07-14

Similar Documents

Publication Publication Date Title
DK0525307T3 (da) Stabile præparater til parenteral indgivelse og deres anvendelse
DK1273288T3 (da) Lægemiddelsammensætning indeholdende rapamycinderivater
CY1108145T1 (el) Σταθερες συνθεσεις για παρεντερικη χορηγηση
DK0810823T3 (da) Sammensætning til bekæmpelse af parasitter
ES2037742T3 (es) Procedimiento de obtencion de una composicion para administracion intravenosa.
DK1383756T3 (da) Cumarinderivater til anvendelse som antikoagulanter
KR900006330A (ko) 피롤로[3,2-e]피라졸로[1,5-a]피리미딘 유도체 및 이를 함유하는 약제
NO912414L (no) Forbindelse med mavesyreinhiberende effekt og fremgangsmaate for dens fremstilling.
DE69331007D1 (de) Difluoroavermectin-derivate
KR950703956A (ko) 순환 장애 개선제[circulatory disturbance ameliorant]
BR0109891A (pt) Composição farmaceutica contendo derivado de camptotecina e substância de ajuste de ph
PT1100463E (pt) Novas formulacoes injectaveis contendo ramoplanina
SE8500962L (sv) Nitrodiarylsulfoxidderivat, forfarande for framstellning derav och farmaceutiska och pesticida kompositioner innehallande dem som aktiv bestandsdel